Non-Hodgkin’s set cell lymphoma is low to intermediate risk and is generally stage II. Set-cell lymphoma is a subtype of non-Hodgkin’s lymphoma and is a moderately aggressive lymphoma. It often has extensive involvement at the time of diagnosis and is one of the poorer prognoses. According to the International Prognostic Index for Lymphoma, non-Hodgkin’s lymphoma can be low-risk, intermediate-risk, or high-risk according to risk. Non-Hodgkin’s condyloma is generally of stage II according to clinical characteristics and symptoms, with lesions involving two or more lymph node regions on the same side of the diaphragm, or with lesions that locally invade organs other than lymph nodes and more than one lymph node region on the same side of the diaphragm. If non-Hodgkin’s set cell lymphoma is diagnosed, early and standardized treatment under the guidance of a physician is recommended to minimize the adverse effects of the disease.